ArticleNPJ breast cancer2023

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.

David B Page et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.